FDA Drug Application (202912) for ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE by LUPIN LTD

Back to FDA Applications sponsored by LUPIN LTD

Application Number202912
Product Number001
FormTABLET;ORAL
DosageEQ 300MG BASE;150MG;300MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE
Active IngredientABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE

Active IngredientCount
List of drugs with Active Ingredient ABACAVIR SULFATE9
List of drugs with Active Ingredient LAMIVUDINE39
List of drugs with Active Ingredient ZIDOVUDINE17


Back to FDA Applications sponsored by LUPIN LTD